SEC 13F Intelligence

Man Group PLC / VRTX

Man Group PLC’s Vertex Pharmaceuticals Inc Position

Does Man Group PLC own Vertex Pharmaceuticals Inc (VRTX)? Yes236.8K shares worth $106M (+0.19% of its 13F portfolio) as of Q1 2026, down from 380.7K shares the prior filed quarter.

Position Value
$106M
Q1 2026
Shares
236.8K
% of Portfolio
+0.19%
Quarters Held
30
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $38MQ4 ’18Q1 ’19: $20MQ2 ’19: $24MQ3 ’19: $11MQ4 ’19: $52MQ4 ’19Q1 ’20: $159MQ2 ’20: $172MQ3 ’20: $193MQ4 ’20: $219MQ4 ’20Q1 ’21: $137MQ2 ’21: $169MQ3 ’21: $220MQ4 ’21: $212MQ4 ’21Q1 ’22: $112MQ2 ’22: $35MQ3 ’22: $68MQ4 ’22: $166MQ4 ’22Q1 ’23: $111MQ2 ’23: $135MQ3 ’23: $95MQ4 ’23: $144MQ4 ’23Q1 ’24: $221MQ2 ’24: $92MQ3 ’24: $24MQ4 ’24: $36MQ4 ’24Q1 ’25: $7MQ2 ’25: $57MQ3 ’25: $142MQ4 ’25: $173MQ4 ’25Q1 ’26: $106Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026236.8K$106M+0.19%
Q4 2025380.7K$173M+0.29%
Q3 2025362.8K$142M+0.25%
Q2 2025127.6K$57M+0.11%
Q1 202515.2K$7M+0.02%
Q4 202488.7K$36M+0.09%
Q3 202451.7K$24M+0.06%
Q2 2024197.3K$92M+0.23%
Q1 2024527.9K$221M+0.56%
Q4 2023354.8K$144M+0.40%
Q3 2023272.8K$95M+0.29%
Q2 2023382.8K$135M+0.42%
Q1 2023353.3K$111M+0.40%
Q4 2022576.4K$166M+0.60%
Q3 2022235.7K$68M+0.32%
Q2 2022122.8K$35M+0.15%
Q1 2022430.8K$112M+0.39%
Q4 2021963.5K$212M+0.68%
Q3 20211.21M$220M+0.77%
Q2 2021840.1K$169M+0.60%
Q1 2021637.4K$137M+0.60%
Q4 2020927.9K$219M+0.96%
Q3 2020710.2K$193M+0.76%
Q2 2020592.4K$172M+0.87%
Q1 2020668.0K$159M+1.03%
Q4 2019236.4K$52M+0.17%
Q3 201964.6K$11M+0.04%
Q2 2019132.4K$24M+0.09%
Q1 2019107.0K$20M+0.07%
Q4 2018230.9K$38M+0.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Man Group PLC’s full portfolio or all institutional holders of VRTX.